LOS ANGELES, CA–(Marketwired – Nov 19, 2013) – Fresh Start Private Management, Inc. (OTCQB: CEYY), a leader in alcohol treatment and rehabilitation programs, announces the establishment of an advisory board. The advisory board will be providing informed guidance to company directors and management.
Dr. George Fallieras and Dr. Lynn Puana join the advisory board as practicing physicians. Dr. Fallieras is board certified in Internal Medicine and Pediatrics, and is the current medical director of Start Fresh Recovery. He is also the Hospitalist Director at Good Samaritan Hospital in LA, a volunteer on medical missions, and is a frequent contributor to various news outlets. Dr. Puana is CEO and Co-Owner of Puana Pain Clinic where she has extensive experience working with addicts. She is helping Fresh Start Private with data collection for future publications that will be written with her husband, Rudolph Puana, MD. Dr. Puana has been published in several peer-reviewed medical journals.
Tom Welch joins the advisory board with experience in healthcare management and recruiting. Joan Pedicini, CEO of Start Fresh Recovery Southwest, also joins the team with a background in accounting. Bill Ferguson rounds out the advisory board and is a practicing attorney in LA for Fowler & Good. For more in-depth backgrounds on each, please read yesterdy’s Form 8-K filing.
“We are thrilled to have an advisory board in place,” said Kent Emry, CEO of Fresh Start Private Management, Inc. “We will look for their advice and guidance moving forward. It’s very important for us to get an outside perspective from trusted professionals.”
About Fresh Start Private
Fresh Start Private Management, Inc. (OTCQB: CEYY) is an alcohol treatment and rehabilitation company on the leading edge of alcohol addiction treatment. The company has developed a highly effective program consisting of two main components used by various alcohol addiction clinics in the US. Clinic reports show that the treatment program has an 85% success rate with individuals that complete the program. The first component of the program consists of an outpatient implant procedure performed by a licensed physician that delivers targeted, therapeutic levels of the drug Naltrexone, an opiate antagonist that significantly reduces physical cravings for alcohol, into the body. The second component of the program developed by Fresh Start Private is a one on one coaching program specifically tailored for the treatment of alcoholism. For more information on CEYY, please visit www.freshstartprivate.com
Safe Harbor Statement
The information in this release includes forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this release. Although the Company believes that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof.
Investor Relations Contact:
Maximum Performance Advisors, Inc.